| HOME >> BIOLOGY >> TECHNOLOGY |
e temperature-dependent response and performance of these materials."
According to J. Karthik, the first author on the group's paper, thin-film epitaxy has been developed to provide a set of parameters (e.g., film composition, epitaxial strain, electrical boundary conditions, and thickness) that allow for precise control of ferroelectrics and has been instrumental in understanding the physics of dielectric and piezoelectric effects.
"We investigated the contribution of 90 domain walls and thermal expansion mismatch to pyroelectricity in ferroelectric PbZr0.2Ti0.8O3 thin films, a widely used material whose bulk ferroelectric and piezoelectric properties are well understood," Karthik explained. As part of this work, Martin's Prometheus research group developed and applied the first phenomenological models to include extrinsic and secondary contributions to pyroelectricity in polydomain films and predict significant extrinsic contributions (arising from the temperature-dependent motion of domain walls) and large secondary contributions (arising from thermal expansion mismatch between the film and the substrate).
"We have also developed and applied a new phase-sensitive pyroelectric current measurement process to measure thin films for the first time and reveal a dramatic increase in the pyroelectric coefficient with increasing fraction of in-plane oriented domains and thermal expansion mismatch consistent with these models," Karthik said.
"By establishing an understanding of the science of these effects, with models to predict their performance, and demonstrated techniques to fabricate and utilize these properties in nanoscale versions of these materials, their properties can be effectively integrated into existing electronics," Martin said.
'/>"/>
| Contact: Lane Martin, Ph.D. lwmartin@illinois.edu 217-244-9162 University of Illinois College of Engineering Source:Eurekalert |
Related biology technology :
1. Trudeau Institute Awarded Grant to Investigate a New Approach to Treating Illnesses Caused by Weaponized and Antibiotic-Resistant Bacteria
2. ViThera Novel Approach Using Probiotics to Deliver Elafin Shows Promise as a Future Inflammatory Bowel Disease (IBD) Treatment
3. ARMGO Pharma, Inc. announces data which supports its Rycal program as a novel approach for the treatment of stress-induced cognitive disorders
4. New Approach to Growing Waste to Value Industry in United States
5. A Genetic Approach For Crohns And Colitis Disease Is Financed By The Jeffrey Epstein VI Foundation
6. Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach
7. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
8. Bayer CropScience Provides a Glimpse of SeedGrowth™ Innovation
9. Organovo Reports Q3 2012 Financial Results, Provides Business Update
10. Tengion Provides Business Update and Reports Third Quarter 2012 Financial Results
11. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Update and Reports Financial Results for Third Quarter 2012
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |